OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.
- Kaynak
- Decrypt
- Yayınlandı
- 2026-10-20 21:46 UTC
- Önbellek güncellendi
- 2026-10-20 21:56 UTC
Bu sayfa yalnızca başlık, özet ve kaynak bilgisini gösterir.
Orijinali aç ↗Transfer ücretlerini kontrol et